Thread
:
DECT trial shows combination of epirubicin and trastuzumab improves outcomes in breas
View Single Post
05-23-2016, 12:37 AM
#
1
News
Senior Member
Join Date: Oct 2007
Posts: 20,103
DECT trial shows combination of epirubicin and trastuzumab improves outcomes in breas
The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab.
More...
News
View Public Profile
Send a private message to News
Find More Posts by News